Swiss Life Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.62M Sell
22,104
-23,272
-51% -$9.84M 0.04% 353
2026
Q1
$21.5M Buy
45,376
+2,005
+5% +$1.01M 0.11% 157
2025
Q4
$20.2M Buy
43,371
+11,373
+36% +$5.28M 0.1% 154
2025
Q3
$13.6M Sell
31,998
-4,701
-13% -$1.82M 0.07% 214
2025
Q2
$14.1M Buy
36,699
+3,251
+10% +$1.17M 0.08% 185
2025
Q1
$11.6M Buy
33,448
+5,132
+18% +$1.65M 0.08% 191
2024
Q4
$8.49M Buy
28,316
+2,617
+10% +$915K 0.06% 218
2024
Q3
$10.4M Sell
25,699
-2,068
-7% -$757K 0.12% 162
2024
Q2
$8.92M Buy
27,767
+2,237
+9% +$727K 0.11% 174
2024
Q1
$8.52M Sell
25,530
-10,639
-29% -$3.25M 0.12% 161
2023
Q4
$9.8M Sell
36,169
-10,621
-23% -$2.63M 0.12% 203
2023
Q3
$11.5M Buy
46,790
+1,265
+3% +$346K 0.18% 132
2023
Q2
$13.8M Sell
45,525
-737
-2% -$205K 0.2% 115
2023
Q1
$12.2M Buy
46,262
+20,090
+77% +$5.1M 0.18% 131
2022
Q4
$6.29M Sell
26,172
-3,440
-12% -$770K 0.11% 232
2022
Q3
$5.44M Sell
29,612
-1,597
-5% -$318K 0.09% 241
2022
Q2
$5.25M Buy
31,209
+744
+2% +$160K 0.08% 263
2022
Q1
$7.63M Sell
30,465
-20,767
-41% -$5.21M 0.11% 207
2021
Q4
$13.2M Buy
51,232
+3,671
+8% +$898K 0.17% 134
2021
Q3
$11.5M Buy
47,561
+2,224
+5% +$544K 0.16% 151
2021
Q2
$8.34M Buy
45,337
+1,373
+3% +$280K 0.08% 227
2021
Q1
$8.28M Buy
43,964
+6,176
+16% +$1.09M 0.12% 212
2020
Q4
$6.21M Buy
37,788
+35,760
+1,763% +$5.23M 0.09% 252
2020
Q3
$253K Buy
+2,028
New +$251K ﹤0.01% 461
2020
Q2
Sell
-2,748
Closed -$247K 519
2020
Q1
$247K Buy
2,748
+523
+24% +$67.7K ﹤0.01% 470
2019
Q4
$329K Sell
2,225
-859
-28% -$115K 0.01% 474
2019
Q3
$371K Sell
3,084
-4,009
-57% -$518K ﹤0.01% 472
2019
Q2
$957K Sell
7,093
-20,324
-74% -$2.57M 0.01% 396
2019
Q1
$3.57M Buy
+27,417
New +$3.68M 0.05% 205
2018
Q4
Sell
-5,491
Closed -$764K 309
2018
Q3
$764K Sell
5,491
-13,275
-71% -$1.65M 0.01% 411
2018
Q2
$1.93M Buy
18,766
+13,722
+272% +$1.39M 0.03% 311
2018
Q1
$489K Sell
5,044
-6,350
-56% -$616K 0.01% 415
2017
Q4
$1M Buy
11,394
+7,382
+184% +$593K 0.02% 346
2017
Q3
$319K Sell
4,012
-17,486
-81% -$1.41M 0.01% 403
2017
Q2
$1.87M Buy
21,498
+8,602
+67% +$728K 0.05% 193
2017
Q1
$1.15M Buy
+12,896
New +$1.08M 0.03% 253
2016
Q4
Sell
-10,616
Closed -$802K 445
2016
Q3
$802K Sell
10,616
-28,411
-73% -$2.18M 0.03% 265
2016
Q2
$3M Buy
+39,027
New +$3.08M 0.12% 112
2015
Q4
Sell
-22,661
Closed -$1.75M 336
2015
Q3
$1.75M Buy
22,661
+8,452
+59% +$748K 0.09% 113
2015
Q2
$1.29M Buy
14,209
+9,875
+228% +$791K 0.05% 128
2015
Q1
$326K Buy
+4,334
New +$311K 0.01% 207

Other funds holding HCA

Swiss Life Asset Management's HCA Position: Q2 2026 in Review

Swiss Life Asset Management reduced its HCA Healthcare (HCA) stake by 51% in Q2 2026, selling an estimated $9.84M and leaving 22,104 shares worth $8.62M. The position accounts for 0.04% of the portfolio, ranked #353.

Swiss Life Asset Management first reported a position in HCA in Q1 2015 and has held it in 41 quarters since. The position peaked at $21.5M in Q1 2026. 934 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Swiss Life Asset Management held 22,104 shares of HCA Healthcare worth $8.62M as of Q2 2026.
  • Swiss Life Asset Management sold 23,272 HCA Healthcare shares in Q2 2026, an estimated $9.84M.
  • HCA Healthcare made up 0.04% of Swiss Life Asset Management's portfolio in Q2 2026, its #353 holding.
  • Swiss Life Asset Management first reported a position in HCA Healthcare in Q1 2015 and has held it in 41 quarters since.
  • Swiss Life Asset Management's HCA Healthcare position peaked at $21.5M in Q1 2026.
  • 934 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.